8th Dec 2005 13:02
GlaxoSmithKline PLC08 December 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in interests in the American Depositary Shares(ADSs) of GlaxoSmithKline plc in respect of the under-mentioned Director:- Dr T Yamada Exercise of options over 74,868 ADSs granted on 25 March 1996, which would if not exercised have lapsed on 25 March 2006, under the SmithKline Beecham US 1991 Share Option Plan at a price of $22.36494 per ADS, followed by the sale of the resulting ADSs. These exercises and sales took place in two tranches: 16,400 ADSs on 6 December 2005 at an average price of $50.52 per share. The Company was advised of these transactions on 7 December 2005. 58,468 ADSs on 7 December 2005 at an average price of $50.1035 per share. The Company was advised of these transactions on 8 December 2005. Dr Yamada's total shareholding in the Company remains 72,805 ADSs. Under the Company's share ownership requirements executive directors, including Dr Yamada, are required to hold a shareholding in the Company to the value of at least three times their annual base salary. Dr Yamada's total shareholding is currently equivalent to more than four and a half times his base salary. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 8 December 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline